Nicolas Stransky

发表

Bioinformatics Original Paper Computation of Recurrent Minimal Genomic Alterations from Array-cgh Data

Céline Rouveirol, Emmanuel Barillot, Eric Viara, 2022 .

VAMP: Visualization and analysis of array-CGH, transcriptome and other molecular profiles

Céline Rouveirol, Emmanuel Barillot, Nicolas Servant, 2006, Bioinform..

Analysis of array CGH data: from signal ratio to gain and loss of DNA regions

Emmanuel Barillot, Jean-Paul Thiery, Philippe Hupé, 2004, Bioinform..

P23: CAP: a Web-based platform for CGH-array management and analysis

Céline Rouveirol, Eric Viara, Emmanuel Barillot, 2005 .

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

Pablo Tamayo, Aviad Tsherniak, Ted Liefeld, 2014, Scientific Data.

Selecting biomedical data sources according to user preferences

Emmanuel Barillot, Sarah Cohen Boulakia, Christine Froidevaux, 2004, ISMB/ECCB.

Abstract 954: The landscape of kinase fusions in cancer

Ethan Cerami, Nicolas Stransky, Christoph Lengauer, 2015 .

Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes

Ethan Cerami, Victor E. Velculescu, Manish Shukla, 2014, Nature Communications.

Targeting cancer with kinase inhibitors.

Nicolas Stransky, Christoph Lengauer, Nicolas Stransky, 2015, The Journal of clinical investigation.

Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles

Chris Sander, Peter W. Laird, Chandra Sekhar Pedamallu, 2017, Cell reports.

ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens

Pablo Tamayo, Aviad Tsherniak, Rameen Beroukhim, 2013, Genome research.

Abstract 105: Integrative analysis of genomic and pharmacologic data from the Cancer Cell Line Encyclopedia

Dmitriy Sonkin, Andrew I. Su, Todd R. Golub, 2010 .

22 The Cancer Cell Line Encyclopedia - Using Preclinical Models to Predict Anticancer Drug Sensitivity

Adam A. Margolin, Nicolas Stransky, Joseph Lehar, 2012 .

COT/MAP3K8 drives resistance to RAF inhibition through MAP kinase pathway reactivation

Marc Vidal, Reinhard Dummer, William C. Hahn, 2010, Nature.

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression

François Radvanyi, Jessica Zucman-Rossi, Jennifer Southgate, 2010, Journal of the National Cancer Institute.

Identification of a proliferation gene cluster associated with HPV E6/E7 expression level and viral DNA load in invasive cervical carcinoma

Eytan Domany, Jérôme Couturier, François Radvanyi, 2005, Oncogene.

Nuclear factor I/B is an oncogene in small cell lung cancer.

Levi Garraway, Derek Y. Chiang, Monte M Winslow, 2011, Genes & development.

Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jill P. Mesirov, Dmitriy Sonkin, Todd R. Golub, 2012, Nature.

Erratum: Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles (Cell Reports (2017) 18(11) (2780–2794) (S2211124717302140) (10.1016/j.celrep.2017.02.033))

Steven J. M. Jones, Chris Sander, Li Ding, 2017 .

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

Eric S. Lander, Petar Stojanov, Todd R. Golub, 2012, Proceedings of the National Academy of Sciences.

Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusion

Kristian Cibulskis, Gad Getz, Shuji Ogino, 2011, Nature Genetics.